Mistletoe IV Therapy
Mistletoe or European Mistletoe (Viscum album) is an herbal medicine with a long history of use with cancer patients. Mistletoe Therapy (Helixor, Iscador and Viscosan) is an alternative cancer treatment for all types of cancer or precancerous conditions. Use of these herbs can be traced back to the 1920s with Rudolf Steiner, PhD, founder of the Society for Cancer Research in Arlesheim, Switzerland. It is given as subcutaneous or intravenous injections.
Clinical data from studies on Mistletoe IV therapy indicate an improvement in overall state and immune system function as well as a decrease in side effects related to chemotherapy. Studies have shown that Mistletoe injections can have the following effects:
- Inhibition of metastasis, and tumor size reduction and necrosis of induced tumors in rodents
- Improved quality of life in patients with cancer tumors including improved mood, endurance, appetite, tolerance of chemotherapy, sleep and decreased fatigue and pain
- Enhancement of immune system including activation of T-helper cells, natural killer cells and other components of the immune system which may target and destroy cancerous cells
- Stabilizing effect on DNA, preventing further mutation into cancer cells
- Alleviation of some side-effects of chemotherapy and radiation
- Mistletoe lectins have been shown to induce apoptosis (cancer cell death). Studies indicate that mistletoe lectins may specifically target some forms of cancer and leave “normal” cells alone. This may be an advantage over chemotherapy which targets any cell, healthy or cancerous.